Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP257 is a pseudogene of the RN7SK gene. Pseudogenes are genomic DNA sequences similar to known genes but typically nonfunctional due to mutations or deletions. RN7SKP257 does not encode a functional small nuclear RNA and does not participate in biological or pathological processes relevant for therapy or drug targeting. The parent gene, RN7SK, encodes a noncoding RNA that regulates transcription elongation by controlling positive transcription elongation factor P-TEFb, but RN7SKP257 itself lacks such biological or clinical relevance[1][2][3][5]. RN7SKP257 should not be confused with RN7SK, which is functionally significant for transcriptional regulation but is itself not a protein-coding therapeutic target, receptor, enzyme, or transporter[1][2]. RN7SKP257 is listed in genomic databases as a pseudogene and not a functional molecule[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 257 (RN7SKP257).